Pain after breast cancer surgery may be associated with underlying depression
the ONA take:
Depression may increase the intensity of postoperative acute pain in women with breast cancer, according to a new study published online ahead of print in the journal Psycho-Oncology.
For the study, researchers sought to determine the prevalence of severe, definite depression symptoms among patients with breast cancer and to assess the association between severe depression symptoms and sociodemographic and perioperative factors during the perioperative period.
Researchers analyzed data from 1,499 women with breast cancer who were admitted for definitive breast surgery. Results showed that 2 or more family members with cancer, having a prescription for sedative medication, and persistent, severe pain during the postoperative period were significantly associated with severe, definite depression symptoms.
The findings suggest that self-reporting of persistent postoperative pain intensity among patients with breast cancer may be useful in identifying hidden depression symptoms during the perioperative period.
Depression may increase the intensity of postoperative acute pain in women with breast cancer.
- Earlier and Later Adult BMI Associated With Multiple Myeloma Risk
- Patients Undergoing Multiple Systemic Therapies for Metastatic Prostate Cancer Expect a Cure
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- E-cigarettes and Replacement Nicotine Therapy Safer Than Tobacco Use
- Cost-Effectiveness of Immunotherapy for Advanced Melanoma Evaluated
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- G-CSF May Help Preserve Fertility in Male Patients With Cancer
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Patients With HER2-enriched Subtype Benefit Most from Dual HER2 Blockade
- Scalp Cooling Reduces Risk of Chemotherapy-Induced Alopecia
- CRISPR Illustrates Progression of Normal Blood Cells to Leukemia, Precursor Diseases
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|